- Home
- AVTX vs CSR Comparison
AVTX vs CSR Comparison
Compare AVTX & CSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AVTX | CSR |
|---|---|---|
| Founded | 2011 | 1970 |
| Country | United States | United States |
| Employees | N/A | 349 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 982.5M | 931.7M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | AVTX | CSR |
|---|---|---|
| Price | $18.96 | $52.28 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 6 |
| Target Price | $40.57 | ★ $69.80 |
| AVG Volume (30 Days) | ★ 718.3K | 108.4K |
| Earning Date | 05-08-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 4.58% |
| EPS Growth | ★ 72.07 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $27,813,137.00 | N/A |
| Revenue This Year | N/A | $1.24 |
| Revenue Next Year | N/A | $2.72 |
| P/E Ratio | ★ N/A | $62.27 |
| Revenue Growth | ★ 2312.27 | N/A |
| 52 Week Low | $9.54 | $52.13 |
| 52 Week High | $24.27 | $69.61 |
Technical Indicators
Market Signals| Indicator | AVTX | CSR |
|---|---|---|
| Relative Strength Index (RSI) | 49.22 | 34.95 |
| Support Level | $18.88 | N/A |
| Resistance Level | $20.60 | $57.76 |
| Average True Range (ATR) | 0.82 | 1.04 |
| MACD | -0.14 | -0.16 |
| Stochastic Oscillator | 33.02 | 2.00 |
Price Performance
Historical ComparisonAbout AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.
About CSR D/B/A Centerspace
Centerspace is a real estate investment trust (REIT) that focuses on the ownership, management, acquisitions, redevelopment, and development of apartment communities. The company operates through a single reportable segment which includes the ownership, management, development, redevelopment, and acquisition of apartment communities and conduct their corporate operations from offices in Minot, North Dakota and Minneapolis, Minnesota.